Item request has been placed!

Item request cannot be made.

Processing Request

Search Results

Display Settings

Results per page: 10

Sort By: Relevance

Your Filters

Publication : journal for immunotherapy of cancer Subject : aged, 80 and over Subject : follicular lymphoma Subject : immunology Filter by : Subject

Item request has been placed!

Item request cannot be made.

Processing Request

Academic Journal

Randomized, open-label, phase 2 study of andecaliximab plus nivolumab versus nivolumab alone in advanced gastric cancer identifies biomarkers associated with survival

Authors : Shah, Manish A; Cunningham, David; Metges, Jean-Philippe

Subjects: Biomedical and Clinical Sciences; Clinical Sciences; Oncology and Carcinogenesis

Source: Journal for ImmunoTherapy of Cancer. 9(12)

Read Online Read More Add to Saved list

Academic Journal

KEYNOTE-022 part 3: a randomized, double-blind, phase 2 study of pembrolizumab, dabrafenib, and trametinib in BRAF-mutant melanoma

Authors : Ferrucci, Pier Francesco; Di Giacomo, Anna Maria; Del Vecchio, Michele

Subjects: Biomedical and Clinical Sciences; Clinical Sciences; Oncology and Carcinogenesis

Source: Journal for ImmunoTherapy of Cancer. 8(2)

Read Online Read More Add to Saved list

Academic Journal

Safety and clinical activity of intratumoral MEDI9197 alone and in combination with durvalumab and/or palliative radiation therapy in patients with advanced solid tumors

Authors : Siu, Lillian; Brody, Joshua; Gupta, Shilpa

Subjects: Biomedical and Clinical Sciences; Clinical Sciences; Oncology and Carcinogenesis

Source: Journal for ImmunoTherapy of Cancer. 8(2)

Read Online Read More Add to Saved list

Academic Journal

Combination immunotherapy induces distinct T-cell repertoire responses when administered to patients with different malignancies.

Authors : Cham, Jason; Zhang, Li; Kwek, Serena

Subjects: CD8-Positive T-Lymphocytes; Humans; Melanoma

Source: Journal for immunotherapy of cancer. 8(1)

Read Online Read More Add to Saved list

Academic Journal

A phase Ib study of utomilumab (PF-05082566) in combination with mogamulizumab in patients with advanced solid tumors

Authors : Cohen, Ezra EW; Pishvaian, Michael J; Shepard, Dale R

Subjects: Biomedical and Clinical Sciences; Oncology and Carcinogenesis; Immunology

Source: Journal for ImmunoTherapy of Cancer. 7(1)

Read Online Read More Add to Saved list

Academic Journal

A robust response to combination immune checkpoint inhibitor therapy in HPV-related small cell cancer: a case report

Authors : Ho, Won Jin; Rooper, Lisa; Sagorsky, Sarah

Subjects: Biomedical and Clinical Sciences; Clinical Sciences; Oncology and Carcinogenesis

Source: Journal for ImmunoTherapy of Cancer. 6(1)

Read Online Read More Add to Saved list

Academic Journal

A hypofractionated radiation regimen avoids the lymphopenia associated with neoadjuvant chemoradiation therapy of borderline resectable and locally advanced pancreatic adenocarcinoma

Authors : Crocenzi, Todd; Cottam, Benjamin; Newell, Pippa

Subjects: Biomedical and Clinical Sciences; Oncology and Carcinogenesis; Immunology

Source: Journal for ImmunoTherapy of Cancer. 4(1)

Read Online Read More Add to Saved list

Phase I, multicenter, open-label study of intravenous VCN-01 oncolytic adenovirus with or without nab-paclitaxel plus gemcitabine in patients with advanced solid tumors

Authors : Rocio Garcia-Carbonero; Miriam Bazan-Peregrino; Marta Gil-Martín ...

Subjects: Cancer Research; Paclitaxel; virus::virus ADN::Adenoviridae [ORGANISMOS]

Source: Dipòsit Digital de la UBUniversidad de BarcelonaScientia

Read Online Read More Add to Saved list

First-in-human study of an OX40 (ivuxolimab) and 4-1BB (utomilumab) agonistic antibody combination in patients with advanced solid tumors

Authors : Omid Hamid; Alberto A Chiappori; John A Thompson ...

Subjects: Pharmacology; Cancer Research; Lung Neoplasms

Source: Journal for ImmunoTherapy of Cancer, 10(10):e005471. BioMed Central Ltd.

Read Online Read More Add to Saved list

Long-term outcomes with nivolumab plus ipilimumab versus sunitinib in first-line treatment of patients with advanced sarcomatoid renal cell carcinoma

Authors : Brian I Rini; Sabina Signoretti; Toni K Choueiri

Subjects: Pharmacology; Cancer Research; Programmed Cell Death 1 Receptor

Source: Rini, B I, Signoretti, S, Choueiri, T K, McDermott, D F, Motzer, R J, George, S, Powles, T, Donskov, F, Tykodi, S S, Pal, S K, Gupta, S, Lee, C W, Jiang, R & Tannir, N M 2022, ' Long-Term outcomes

Read Online Read More Add to Saved list